Jian Pang

Prognostic value of baseline neutrophil/lymphocyte ratio in HER2-positive metastatic breast cancer: exploratory analysis of data from the CLEOPATRA trial

N. Ding, Ying-jian He, Zhi Xiao, 2024, Breast cancer research : BCR.

Systemic immune-inflammation index as a prognostic marker in HER2-positive breast cancer patients undergoing trastuzumab therapy

N. Ding, Zhi Xiao, Jian Pang, 2024, Scientific reports.

Comparing long-term prognosis following different surgical methods in patients with early stage breast cancer and obesity: a retrospective cohort study in China

Ming Chen, Qi Zhang, Shuyue Zheng, 2024, BMJ open.